First experience with a new negative pressure incision management system on surgical incisions after cardiac surgery in high risk patients

Journal of Cardiothoracic Surgery

Andrea Colli¹ 

[1] Department of Cardiac Surgery, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

关键词: median sternotomy;    cardiac surgery;    negative pressure wound therapy;    wound healing;    incision;   

Others  :  1153586
DOI  :  10.1186/1749-8090-6-160

 received in 2011-09-21, accepted in 2011-12-06,  发布年份 2011

【 摘 要 】

Background

Sternal wound infection remains a serious potential complication after cardiac surgery. A recent development for preventing wound complications after surgery is the adjunctive treatment of closed incisions with negative pressure wound therapy. Suggested mechanisms of preventive action are improving the local blood flow, removing fluids and components in these fluids, helping keep the incision edges together, protecting the wound from external contamination and promoting incision healing. This work reports on our initial evaluation and clinical experience with the Prevena™Incision Management System, a recently introduced new negative pressure wound therapy system specifically developed for treating closed surgical incisions and helping prevent potential complications. We evaluated the new treatment on sternal surgical incisions in patients with multiple co-morbidities and consequently a high risk for wound complications.

Methods

The Prevena™incision management system was used in 10 patients with a mean Fowler risk score of 15.1 [Range 8-30]. The negative pressure dressing was applied immediately after surgery and left in place for 5 days with a continuous application of -125 mmHg negative pressure. Wounds and surrounding skin were inspected immediately after removal of the Prevena™ incision management system and at day 30 after surgery.

Results

Wounds and surrounding skin showed complete wound healing with the absence of skin lesions due to the negative pressure after removal of the Prevena™ dressing. No device-related complications were observed. No wound complications occurred in this high risk group of patients until at least 30 days after surgery.

Conclusions

The Prevena™system appears to be safe, easy to use and may help achieve uncomplicated wound healing in patients at risk of developing wound complications after cardiothoracic surgery.

【 授权许可】

   
2011 Colli; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ: The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000, 118:397-402.
• [2]El Oakley RM, Wright JE: Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996, 61:1030-1036.
• [3]Braxton JH, Marrin CA, McGrath PD, Ross CS, Morton JR, Norotsky M, Charlesworth DC, Lahey SJ, Clough RA, O'Connor GT, Northern New England Cardiovascular Disease Study Group: Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000, 70:2004-2007.
• [4]Graf K, Ott E, Vonberg RP, Kuehn C, Haverich A, Chaberny IF: Economic aspects of deep sternal wound infections. Eur J Cardiothorac Surg 2010, 37:893-896.
• [5]Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry MC, Goormastic M, Stewart RW, Golding LA, Taylor PCJ: Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990, 49:179-86.
• [6]Toumpoulis IK, Anagnostopoulos CE, Derose JJ Jr: Swistel DG.The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest 2005, 127:464-71.
• [7]Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ: The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000, 118:397-402.
• [8]Mokhtari A, Sjögren J, Nilsson J, Gustafsson R, Malmsjö M, Ingemansson R: The cost of vacuum-assisted closure therapy in treatment of deep sternal wound infection. Scandinavian Cardiovascular Journal 2008, 42:85-89.
• [9]Nettleman MD: Current efficacy of infection control: Costs and cost benefit. In Prevention and control of Nosocomial Infections. 4th edition. Edited by Wenzel RP. Lippincott, Williams & Wilkins, Philadelphia; 2003:33-41.
• [10]Lu JC, Grayson AD, Jha P, Srinivasan AK, Fabri BM: Risk factors for sternal wound infection and mid-term survival following coronary artery bypass surgery. Eur J Cardiothorac Surg 2003, 23:943-949.
• [11]Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H: Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg 2001, 20:1168-1175.
• [12]Sjogren J, Nilsson J, Gustafsson R, Malmsjo M, Ingemansson R: The impact of vacuum-assisted closure on long-term survival after post-sternotomy mediastinitis. Ann Thorac Surg 2005, 80:1270-1275.
• [13]Fowler VG Jr, O'Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED: Clinical predictors of major infections after cardiac surgery. Circulation 2005, 112(suppl 1):I358-I365.
• [14]Towfigh S, Cheadle WG, Lowry SF, Malangoni MA, Wilson SE: Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Arch Surg 2008, 143:885-91.
• [15]Schimmer C, Sommer SP, Bensch M, Bohrer T, Aleksic I, Leyh R: Sternal closure techniques and postoperative sternal wound complications in elderly patients. Eur J Cardiothorac Surg 2008, 34:132-138.
• [16]Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J: Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg 2004, 26:367-372.
• [17]Reiss N, Schuett U, Kemper M, Bairaktaris A, Koerfer R: New method for sternal closure after vacuum-assisted therapy in deep sternal infections after cardiac surgery. Ann Thor Surg 2007, 83:2246-2247.
• [18]Johnson RG, Cohn WE, Thurer RL, McCarthy JR, Sirois CA, Weintraub RM: Cutaneous closure after cardiac operations: a controlled, randomized, prospective comparison of intradermal versus staple closures. Ann Surg 1997, 226:606-612.
• [19]Chughtai T, Chen LQ, Salasidis G, Nguyen D, Tchervenkov C, Morin JF: Clips versus suture technique: is there a difference? Can J Cardiol 2000, 16:1403-1407.
• [20]Chambers A, Scarci M: Is skin closure with cyanoacrylate glue effective for the prevention of sternal wound infections? Interact Cardiovasc Thorac Surg 2010, 10:793-796.
• [21]Bennett-Guerrero E, Ferguson TB Jr, Lin M, Garg J, Mark DB, Scavo VA Jr, Kouchoukos N, Richardson JB Jr, Pridgen RL, Corey GR, SWIPE-1 Trial Group: Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA 2010, 304:755-762.
• [22]Khalafi RS, Bradford DW, Wilson MG: Topical application of autologous blood products during surgical closure following a coronary artery bypass graft. Eur J Cardiothorac Surg 2008, 34:360-364.
• [23]Teshima H, Kawano H, Kashikie H, Nakamura K, Imada T, Oda T, Aoyagi S: A new hydrocolloid dressing prevents surgical site infection of median sternotomy wounds. Surg Today 2009, 39:848-854.
• [24]Vang SN, Brady CP, Christensen KA, Allen KR, Anderson JE, Isler JR, Holt DW, Smith LM: Autologous platelet gel in coronary artery bypass grafting: effects on surgical wound healing. J Extra Corpor Technol 2007, 39:31-38.
• [25]Stannard JP, Robinson JT, Anderson ER, McGwin G Jr, Volgas DA, Alonso JE: Negative pressure wound therapy to treat hematomas and surgical incisions following high-energy trauma. J Trauma 2006, 60:1301-1306.
• [26]Stannard JP, Atkins BZ, O'Malley D, Singh H, Bernstein B, Fahey M, Masden D, Attinger CE: Use of negative pressure therapy on closed surgical incisions: a case series. Ostomy Wound Manage 2009, 55:58-66.
• [27]Atkins BZ, Wooten MK, Kistler J, Hurley K, Hughes GC, Wolfe WG: Does negative pressure wound therapy have a role in preventing poststernotomy wound complications? Surg Innov 2009, 16:140-146.
• [28]Gomoll AH, Lin A, Harris MB: Incisional vacuum-assisted closure therapy. J Orthop Trauma 2006, 20:705-709.
• [29]Wilkes RP, Kilpadi DV, Zhao Y, Kazala R, McNulty A: Closed Incision Management With Negative Pressure Wound Therapy (CIM): Biomechanics. Surg Inno, in press.
• [30]Kilpadi DV, Cunningham MR: Evaluation of closed incision management with negative pressure wound therapy (CIM): Hematoma/seroma and involvement of the lymphatic system. Wound Repair and Regeneration 2011, 19:588-596.
• [31]Pachowsky M, Gusinde J, Klein A, Lehrl S, Schulz-Drost S, Schlechtweg P, Pauser J, Gelse K, Brem MH: Negative pressure wound therapy to prevent seromas and treat surgical incisions after total hip arthroplasty. Int Orthop, in press.
• [32]Dohmen PM: Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections. J Hosp Infect 2008, 70(Suppl 2):15-20.
• [33]Howard DH, Scott RD, Packard R, Jones D: The global impact of drug resistance. Clin Infect Dis 2003, 36:S4-S10.